Rise and shine, another chilly day is on the way. A shiny frost has enveloped the Pharmalot corporate campus this morning as we struggle to fire the furnace and deposit the short people at various houses of learning. Another way to keep warm, of course, is to reach for that fabled cup of stimulation. As always, we invite you to join us. Meanwhile, here are some tidbits. Have a great day and stay in touch...
Lawyers Resolve Dispute Over Glaxo Settlement Fees (Bloomberg News)
Botox Maker Allergan To Buy MAP Pharmaceuticals (Los Angeles Times)
Vanda Sleep Drug Effective In Late-Stage Trial (Reuters)
China SFDA Orders API Export Survey (Xinhua News Agency)
Evidence Grows For Narcolepsy Link To Glaxo Vaccine (Reuters)
J&J Predicted 37 Percent Hip Implant Failure Rate (Bloomberg News)
Celgene Drug Shows Promise In Treating Pancreatic Cancer (New York Times)
NICE OKs Eliquis Bloodthinner For Irregular Heartbeat Patients (Bloomberg News)
EDITOR'S NOTE: Please check this post for additional items during the day
icycles pic thx to iowaspiritwalker on flickr